Polyclonal antibodies derived from dengue virus immune sera and 3H5 monoclo
nal antibody showed potent neutralisation effect on dengue-2 virus in the p
laque reduction neutralisation assay. This study demonstrated that antibodi
es present in immune human sera and 3H5 monoclonal antibody neutralised den
gue-2 virus by altering the virus entry pathway into cells. In the presence
of neutralising antibodies, dengue-2 virus was endocytosed by LLC-MK2 cell
s. The endocytosis process involved ruffling of antibody-coated virions by
cellular pseudopodia and invagination of cell membrane. This mode of entry
is atypical as compared to direct fusion of dengue-2 virus with cell membra
ne in the absence of antibody. The virions were internalised in the form of
virion-antibody complexes consisting of single or clumps of virions. After
3 minutes of incubation, neutralised virions were detected in cellular ves
icles, and signs of intra-endosomal penetration into cytoplasm were not evi
dent even after a prolonged incubation of 10 minutes, suggesting that viral
uncoating was compromised. Vesicle-bound virions were no longer detected a
fter 20 minutes of incubation. In addition, no sign of viral replication wa
s detected in cells infected with "neutralised" virions by immunofluorescen
ce assay. This indicated that internalised virions had been degraded leadin
g to abortive infection. in conclusion, antibodies present in 3H5 monoclona
l antibody and human immune sera rendered dengue-2 virus non-infective by n
eutralising the viral fusion site and causing alteration of viral entry mod
e. Antibodies in immune sera but not 3H5 monoclonal antibody also exerted m
inimal inhibitory effect on virus binding and internalisation. J. Med. Viro
l. 62:364-376, 2000. (C) 2000 Wiley-Liss, Inc.